Department of Internal Medicine, Fukuoka Dental College Medical and Dental Hospital, 2-15-1 Tamura, Sawara-ku, Fukuoka 814-0193, Japan.
Curr Pharm Des. 2011;17(5):424-33. doi: 10.2174/138161211795164149.
Cerebrovascular disease is the leading cause of death and disability in Japan and most Western countries. Gene transfer techniques may be applicable to the treatment of serious types of stroke, since several experimental studies have revealed the usefulness of gene therapy in the protection of neurons, reduction of infarct size and improvement of function. Prevention of vasospasm after subarachnoid hemorrhage is one of the best candidates for vascular gene therapy. Ischemia-induced apoptosis, inflammation, and derangement of neurovascular units can be targeted by the gene transfer approach. Recent studies have shown that promotion of neurogenesis and functional recovery may also be achieved by this strategy. Furthermore, a combination of stem cell therapy with gene transfer methods may be feasible. This review describes novel approaches for the treatment of stroke using gene transfer techniques.
脑血管病是日本和大多数西方国家的主要死亡和致残原因。基因转移技术可能适用于严重类型中风的治疗,因为几项实验研究表明,基因治疗在保护神经元、减少梗死面积和改善功能方面具有一定的作用。蛛网膜下腔出血后预防血管痉挛是血管基因治疗的最佳候选者之一。基因转移方法可以针对缺血诱导的细胞凋亡、炎症和神经血管单元的失调进行靶向治疗。最近的研究表明,通过这种策略还可以促进神经发生和功能恢复。此外,干细胞治疗与基因转移方法的结合可能是可行的。本文综述了使用基因转移技术治疗中风的新方法。